EffRx is attending the Swiss Biotech Day 2026, taking place on May 4–5, 2026, in Basel. Recognized as one of Europe’s leading biotech conferences, it brings together an international community of life sciences professionals, including industry leaders, researchers, investors, and strategic partners.

Over the years, Swiss Biotech Day has grown significantly in both scale and international reach, reinforcing its role as an important platform for cross-border collaboration and global biotech connections. Swiss Biotech Day 2026 will spotlight R&D, manufacturing, data, AI, and innovative financing through expert talks, company showcases, partnering meetings, and an exhibition, creating an interactive environment that facilitates knowledge exchange and new partnership opportunities.

EffRx seeks in-licensing opportunities in Switzerland and in Europe, with a focus on niche therapeutic areas such as rare diseases, endocrinology, and musculoskeletal disorders. The conference offers an ideal platform for EffRx to engage with potential partners across the biotech and healthcare ecosystem.